These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

849 related items for PubMed ID: 19509125

  • 1. Preeclampsia: the role of angiogenic factors in its pathogenesis.
    Wang A, Rana S, Karumanchi SA.
    Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
    [Abstract] [Full Text] [Related]

  • 2. The role of angiogenic factors in pre-eclampsia.
    Abimanyu B.
    Pregnancy Hypertens; 2014 Jul; 4(3):246. PubMed ID: 26104650
    [Abstract] [Full Text] [Related]

  • 3. Angiogenic factors in the pathogenesis of preeclampsia.
    Yuan HT, Haig D, Ananth Karumanchi S.
    Curr Top Dev Biol; 2005 Jul; 71():297-312. PubMed ID: 16344109
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Angiogenic factors and their role in pathogenesis and prediction of preeclampsia].
    Stepan H, Jank A.
    Z Geburtshilfe Neonatol; 2009 Jun; 213(3):101-5. PubMed ID: 19536710
    [Abstract] [Full Text] [Related]

  • 7. Vascular biology of preeclampsia.
    Myatt L, Webster RP.
    J Thromb Haemost; 2009 Mar; 7(3):375-84. PubMed ID: 19087223
    [Abstract] [Full Text] [Related]

  • 8. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S, Karumanchi SA.
    Nephron Clin Pract; 2007 Mar; 106(2):c72-81. PubMed ID: 17570933
    [Abstract] [Full Text] [Related]

  • 9. Preeclampsia: current understanding of the molecular basis of vascular dysfunction.
    Sankaralingam S, Arenas IA, Lalu MM, Davidge ST.
    Expert Rev Mol Med; 2006 Jan 26; 8(3):1-20. PubMed ID: 16438753
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Angiogenic factors and preeclampsia.
    Steinberg G, Khankin EV, Karumanchi SA.
    Thromb Res; 2009 Jan 26; 123 Suppl 2():S93-9. PubMed ID: 19217486
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The pathogenesis of preeclampsia].
    van Beek E, Peeters LL.
    Ned Tijdschr Geneeskd; 1997 Jul 12; 141(28):1379-84. PubMed ID: 9380198
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
    Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S.
    J Reprod Immunol; 2009 Nov 12; 82(2):106-11. PubMed ID: 19853925
    [Abstract] [Full Text] [Related]

  • 18. Immunology and genetic of preeclampsia.
    Serrano NC.
    Clin Dev Immunol; 2006 Nov 12; 13(2-4):197-201. PubMed ID: 17162362
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.